av/viemed-healthcare--big.svg

NASDAQ:VMD

Viemed Healthcare, Inc.

  • Stock

USD

Last Close

10.16

21/12 21:00

Market Cap

402.21M

Beta: 0.93

Volume Today

22.19K

Avg: 121.44K

PE Ratio

34.20

PFCF: 19.00

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
average inventory
1.64M
-
2.26M
38.18%
2.12M
6.04%
1.83M
13.59%
2.38M
29.89%
3.02M
26.52%
average payables
2.63M
-
4.63M
75.93%
5.29M
14.17%
3.40M
35.79%
2.67M
21.50%
2.94M
10.38%
average receivables
7.29M
-
9.31M
27.76%
10.19M
9.41%
11.95M
17.35%
13.54M
13.31%
15.06M
11.19%
book value per share
0.34
-
0.63
84.35%
0.92
47.61%
1.16
25.32%
2.11
81.99%
2.40
13.87%
2.51
4.61%
capex per share
-0.04
-
-0.11
139.13%
-0.16
52.81%
-0.35
119.94%
-0.34
5.13%
-0.50
48.49%
-0.59
18.49%
capex to depreciation
-1.18
-
-1.57
33.90%
-1.62
2.67%
-2.09
29.40%
-1.36
34.91%
-1.75
28.21%
-1.47
16.06%
capex to operating cash flow
-0.26
-
-0.33
27.56%
-0.27
17.90%
-0.70
156.56%
-0.37
47.02%
-0.88
136.25%
-0.83
5.98%
capex to revenue
-0.05
-
-0.09
59.78%
-0.09
9.81%
-0.17
78.05%
-0.10
40.44%
-0.17
69.78%
-0.16
2.21%
cash per share
0.11
-
0.13
17.49%
0.27
104.35%
0.35
28.85%
0.80
125.83%
0.72
10.04%
0.44
39.17%
days of inventory on hand
47.84
-
48.41
1.18%
63.14
30.44%
20.47
67.58%
16.47
19.55%
20.54
24.75%
24.09
17.26%
days payables outstanding
55.00
-
100.37
82.51%
128.69
28.21%
70.74
45.03%
14.94
78.88%
27.08
81.25%
17.86
34.05%
days sales outstanding
55.79
-
76.08
36.35%
49.43
35.03%
52.46
6.13%
34.39
34.43%
45.88
33.41%
40.50
11.73%
debt to assets
0.26
-
0.14
47.75%
0.06
53.43%
0.24
269.16%
0.10
58.12%
0.06
44.14%
0.01
89.27%
debt to equity
0.50
-
0.22
56.71%
0.10
55.18%
0.45
356.69%
0.14
69.47%
0.07
49.57%
0.01
89.60%
dividend yield
earnings yield
0.02
-
0.13
606.62%
0.07
45.47%
0.04
48.47%
0.10
188.32%
0.04
57.54%
0.02
51.90%
enterprise value
69.66M
-
63.69M
8.57%
138.19M
116.98%
242.14M
75.22%
282.87M
16.82%
184.48M
34.78%
276.29M
49.77%
enterprise value over ebitda
11.27
-
3.86
65.76%
6.63
71.99%
15.50
133.65%
8.29
46.53%
7.76
6.44%
11.24
44.98%
ev to operating cash flow
10.86
-
5.30
51.23%
6.18
16.64%
12.69
105.35%
8.06
36.49%
8.20
1.80%
9.96
21.41%
ev to sales
2.22
-
1.36
38.91%
2.12
56.01%
3.02
42.51%
2.15
28.60%
1.58
26.84%
1.99
26.28%
free cash flow per share
0.13
-
0.21
69.22%
0.43
102.74%
0.15
64.76%
0.57
276.73%
0.07
87.77%
0.13
80.11%
free cash flow yield
0.07
-
0.13
79.59%
0.11
11.22%
0.02
78.42%
0.07
201.68%
0.01
81.71%
0.02
24.38%
graham net net
-0.08
-
-0.02
77.13%
-0.00
99.10%
-0.43
260,489.25%
0.27
163.35%
0.44
63.05%
0.27
39.94%
graham number
0.50
-
1.74
250.34%
2.36
35.58%
2.43
2.69%
6.21
155.98%
3.53
43.14%
3.02
14.64%
income quality
5.22
-
1.47
71.84%
2.20
49.45%
2.24
1.87%
1.11
50.26%
2.46
121.35%
4.46
80.93%
intangibles to total assets
0
-
0
0
0
0
0
0
interest coverage
1.19
-
32.44
2,635.90%
94.17
190.28%
27.86
70.42%
52.61
88.88%
36.42
30.79%
41.89
15.03%
interest debt per share
0.18
-
0.14
19.99%
0.10
33.82%
0.53
452.33%
0.30
42.82%
0.17
42.40%
0.02
86.68%
inventory turnover
7.63
-
7.54
1.17%
5.78
23.33%
17.83
208.45%
22.16
24.30%
17.77
19.84%
15.15
14.72%
invested capital
0.50
-
0.22
56.71%
0.10
55.18%
0.45
356.69%
0.14
69.47%
0.07
49.57%
0.01
89.60%
market cap
67.50M
-
63.60M
5.78%
145.18M
128.25%
235.98M
62.55%
302.71M
28.28%
206.37M
31.83%
292.51M
41.74%
net current asset value
-603K
-
3.05M
606.47%
4.47M
46.40%
-11.09M
347.95%
16.31M
247.10%
24.17M
48.20%
19.79M
18.10%
net debt to ebitda
0.35
-
0.00
98.59%
-0.34
6,938.19%
0.39
217.47%
-0.58
247.56%
-0.92
58.23%
-0.66
28.27%
net income per share
0.03
-
0.22
565.80%
0.27
24.53%
0.23
15.84%
0.81
260.05%
0.23
71.60%
0.16
30.35%
operating cash flow per share
0.17
-
0.32
87.46%
0.59
86.11%
0.51
14.27%
0.91
79.07%
0.57
37.15%
0.72
26.02%
payables turnover
6.64
-
3.64
45.21%
2.84
22.00%
5.16
81.91%
24.43
373.42%
13.48
44.83%
20.43
51.63%
receivables turnover
6.54
-
4.80
26.66%
7.38
53.91%
6.96
5.77%
10.61
52.52%
7.95
25.04%
9.01
13.29%
research and ddevelopement to revenue
0.01
-
0.01
21.94%
0.02
118.54%
0.02
7.74%
return on tangible assets
0.05
-
0.22
335.95%
0.19
12.35%
0.10
45.72%
0.28
171.40%
0.08
72.38%
0.05
31.29%
revenue per share
0.83
-
1.24
49.66%
1.72
39.15%
2.13
23.53%
3.39
59.28%
2.96
12.54%
3.59
21.16%
roe
0.10
-
0.34
261.16%
0.29
15.64%
0.20
32.84%
0.39
97.84%
0.10
75.06%
0.06
33.42%
roic
0.17
-
0.26
52.05%
0.40
55.10%
0.12
71.15%
0.33
187.66%
0.08
75.09%
0.06
29.97%
sales general and administrative to revenue
0.44
-
0.43
1.75%
0.47
8.95%
0.56
19.99%
0.44
22.08%
0.51
16.70%
0.53
3.02%
shareholders equity per share
0.34
-
0.63
84.35%
0.92
47.61%
1.16
25.32%
2.11
81.99%
2.40
13.87%
2.51
4.61%
stock based compensation to revenue
0.02
-
0.04
134.62%
0.05
16.97%
0.04
23.21%
0.04
18.33%
0.04
14.83%
tangible asset value
12.88M
-
23.74M
84.35%
35.03M
47.54%
43.70M
24.74%
81.69M
86.94%
94.82M
16.07%
97.09M
2.40%
tangible book value per share
0.34
-
0.63
84.35%
0.92
47.61%
1.16
25.32%
2.11
81.99%
2.40
13.87%
2.51
4.61%
working capital
2.03M
-
3.85M
89.94%
5.98M
55.30%
1.90M
68.25%
24.16M
1,172.14%
29.50M
22.11%
20.88M
29.21%

All numbers in USD (except ratios and percentages)